Wednesday, July 8, 2026

Drug profile · INN

indapamide

indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — indapamide
US status
approved
Class
Route
ORAL
Patents
0
Programs
6
Data quality
0.89

Quick answer

indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN indapamide
Brand APO-INDAPAMIDE SR
Mechanism Thiazide-sensitive sodium-chloride cotransporter inhibitor
Target Solute carrier family 12 member 3
Route ORAL
Formulation TABLET

Mechanism of action

Thiazide-sensitive sodium-chloride cotransporter inhibitor

Primary target: Solute carrier family 12 member 3

Approval history

Authority Status Date
FDA approved
TGA approved

Pipeline programs

  1. Indapamide Phase 2 · Alnylam Netherlands · Hypertension
  2. 204-PKT-202301 Phase 1 · APREMEDA s.r.o · high blood pressure
  3. A single-dose for hypertension Phase 1 · Anaxis Pharma · hypertension
  4. INSIGHT Phase 1 · George Institute for · Histologically confirmed locally advanced or metastatic soli
  5. S005183-297 Phase 1 · George Institute for · No medical condition.
  6. S005183-303 Phase 1 · George Institute for · No medical condition.

Related & competitor drugs

  1. chlorothiazide sodium Thiazide-sensitive sodium-chloride cotransporter inhibitor
  2. chlorthalidone Thiazide-sensitive sodium-chloride cotransporter inhibitor
  3. hydrochlorothiazide Thiazide-sensitive sodium-chloride cotransporter inhibitor
  4. bendroflumethiazide Thiazide-sensitive sodium-chloride cotransporter inhibitor
  5. benzthiazide Thiazide-sensitive sodium-chloride cotransporter inhibitor
  6. chlorothiazide Thiazide-sensitive sodium-chloride cotransporter inhibitor

Frequently asked questions

What is indapamide?

indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for indapamide?

APO-INDAPAMIDE SR is a marketed brand name for indapamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of indapamide?

indapamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.